Navigation Links
SphygmoCor Mx Central Blood Pressure Monitoring System

ProductsSphygmoCor Mx Central Blood Pressure Monitoring System
Company AtCor Medical Pty Ltd.
Item SphygmoCor Mx Central Blood Pressure Monitoring System
Features Benefits:

The SphygmoCor Mx Central Blood Pressure Monitoring System now makes it easier for you to monitor the "definitive" blood pressure the pressure at the heart.

The system:

  • Monitors the complete aortic blood pressure profile that is seen by the left ventricle, the coronary arteries and the baro-receptors - not just the max/min pressure values seen in the radial artery.
  • Monitors central blood pressure the pressure that drives the cerebral blood flow.
  • Tracks dynamic changes in LV load and subendocardial viability
  • Monitors subtle pressure waveform changes, not just max/min values of blood pressure.
Description The SphygmoCor Mx Central Blood Pressure Monitoring System extends the capabilities of the SphygmoCor Px system by providing continuous, real-time derivation of the aortic pressure waveform.

Key cardiovascular parameters are sampled every 5 seconds, and trended. These parameters include:

  • Central Systolic, Diastolic, and Pulse Pressures
  • Augmentation Index a measure of the clinical impact of arterial stiffness on the heart
  • Ejection Duration systolic timing, and hence an indicator of myocardial demand
  • Subendocardial Viability Ratio a measure of cardiac reserve
The SphygmoCor Mx System also allows reports to be generated at regular intervals, or whenever required.

The SphygmoCor Mx System utilizes a continual radial artery pressure waveform input. This can be from either a radial artery catheter and BP monitor or a non-invasive radial artery pressure waveform monitor (calibrated or non-calibrated).

Info AtCor Medical Pty Ltd.
Customer Service: (630) 799-8217
Web site: http://www.atcormedical.com/

Related medicine products :

1. SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System
2. SphygmoCor Px Central Blood Pressure Assessment and Management System
3. SphygmoCor Px Pulse Wave Analysis System test
4. Innotrac Aio! Central
5. Endoalpha Centralized O.R. Control System
6. Centralized Holter Analysis
7. S/5 iCentral
8. Acuity LT Central Station
9. Mobile Acuity LT™ Central Station
10. Acuity® Central Station
11. Oxinet III Central Station Network
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Survivors of childhood cancer less likely to marry 10291 1Survivors of childhood cancer less likely to marry 10291 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 1HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 3Statewide Drug Card Program Launching 59108 1